Rheumatoid Arthritis Clinical Trial
Official title:
A Multicentre, Prospective Clinical Study Analysing Outcomes of Shoulder Arthroplasty With SMR STEMLESS
Verified date | March 2024 |
Source | Limacorporate S.p.a |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Shoulder arthroplasty is a reliable procedure for the treatment of severe shoulder joint diseases to relieve pain and restore shoulder function. Shoulder implants commonly used are characterised by a humeral stem and complications related to the stem are not infrequent. These include: bone stock loss, intraoperative and postoperative break around the implant, malpositioning of the humeral component and difficult eradication of infections inside the bone around the implant. With the aim of reducing stem-related complications, a novel prosthesis characterised by a stem-less design has been developed. The objective of this study is therefore to explore how well people recover after shoulder replacement with this novel stem-less shoulder prosthesis. This will be assessed over 5 years in three different countries in Europe using patient completed questionnaires and clinical and radiographic assessments.
Status | Active, not recruiting |
Enrollment | 78 |
Est. completion date | December 2024 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Patients meeting all the following inclusion criteria will be considered for participation in the study: 1. Both genders; 2. Age = 18 years old; 3. Full skeletal maturity; 4. Life expectancy over 5 years; 5. Patient is requiring primary unilateral or bilateral anatomic or reverse arthroplasty based on physical examination and medical history; 6. Good bone quality evaluated by the Investigator on the basis of a risk factors analysis (included MORES/SCORE questionnaires) and the intraoperative evaluation; 7. A diagnosis in the target shoulder of one or more of the following: - Primary osteoarthritis; - Secondary osteoarthritis; - Post-traumatic arthritis; - Rheumatoid arthritis; - Avascular necrosis of the humeral head (radiologically less than 20%); - Cuff tear arthropathy. 8. Patient submitted to previous conservative non-surgical treatments; 9. Patient is willing and able to complete scheduled follow-up evaluations as described in the Patient Information Sheet; 10. Patient has participated in the Informed Consent process and has signed the Informed Consent form previously approved by the Ethics Committee. Patients will be excluded if they meet any of the following criteria: 1. Patient requiring revision shoulder arthroplasty; 2. Osteoporosis with a history of non-traumatic fractures; 3. Steroid injections within the previous 3 months; 4. Contralateral shoulder replacement within the previous 3 months; 5. Extensive avascular necrosis (radiologically more than 20%); 6. Meta-epiphyseal bony defect (including large cysts); 7. Post-traumatic tuberosity non-union; 8. Ongoing septicaemia; 9. Significant proven or suspicious infection of the target shoulder or any serious infectious disease before the study according to the Investigator; 10. Significant neurological or musculoskeletal disorders that may compromise functional recovery; 11. Not recovered axillary nerve palsy; 12. Non functioning deltoid muscle; 13. Known or suspicious hypersensitivity to the metal or other components and materials of the implant; 14. Recurrent medical history of immune-mediated reactions or other systemic immune disorders; 15. Current treatment or treatment for any malignancy within the previous 2 years before the preoperative visit; 16. Previous organ transplant; 17. Any intercurrent chronic disease or condition and any significant finding that may interfere with the completion of the 60-month follow-up, such as liver disease, severe coronary disease, or other clinically significant condition that the Investigator feels may affect the study evaluation; 18. Unwillingness or inability (alcoholism, infirmity) to comply with rehabilitation and to return for follow-up visits and any psychiatric illness that would prevent comprehension of the details and nature of the study; 19. Participation in any experimental drug/device study within the 6 months prior to the preoperative visit; |
Country | Name | City | State |
---|---|---|---|
Germany | St. Anna Hospital | Herne | |
Netherlands | Spaarne Hospital | Hoofddorp | |
Netherlands | Zorgsaam Zorggroep Ziekhenhuis Terneuzen | Terneuzen | |
United Kingdom | North Bristol NHS | Bristol |
Lead Sponsor | Collaborator |
---|---|
Limacorporate S.p.a |
Germany, Netherlands, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Efficacy as assessed by proportion of patients reaching a clinical progression measured as Constant score change | Constant score change of greater than 10 points | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |